Recovery of ΔF508-CFTR Function by Citrate

Overview

Journal Nutrients

Date 2022 Oct 27

PMID 36296967

Authors

Beatrice Borkenhagen

Peter Prehm

Affiliations

Soon will be listed here.

Abstract

Treatment of cystic fibrosis relies so far on expensive and sophisticated drugs. A logical approach to rescuing the defective ΔF508-CFTR protein has not yet been published. Therefore, virtual docking of ATP and CFTR activators to the open conformation of the CFTR protein was performed. A new ATP binding site outside of the two known locations was identified. It was located in the cleft between the nucleotide binding domains NBD1 and NBD2 and comprised six basic amino acids in close proximity. Citrate and isocitrate were also bound to this site. Citrate was evaluated for its action on epithelial cells with intact CFTR and defective ΔF508-CFTR. It activated hyaluronan export from human breast carcinoma cells and iodide efflux, and recovered ΔF508-CFTR from premature intracellular degradation. In conclusion, citrate is an activator for ΔF508-CFTR and increases export by defective ΔF508-CFTR into the extracellular matrix of epithelial cells.

Citing Articles

Computational Exploration of Potential CFTR Binding Sites for Type I Corrector Drugs.

Lester A, Sandman M, Herring C, Girard C, Dixon B, Ramsdell H Biochemistry. 2023; 62(16):2503-2515.

PMID: 37437308 PMC: 10433520. DOI: 10.1021/acs.biochem.3c00165.

References

Ma T, Thiagarajah J, Yang H, Sonawane N, Folli C, Galietta L . Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest. 2002; 110(11):1651-8. PMC: 151633. DOI: 10.1172/JCI16112. View

Serohijos A, Hegedus T, Aleksandrov A, He L, Cui L, Dokholyan N . Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function. Proc Natl Acad Sci U S A. 2008; 105(9):3256-61. PMC: 2265173. DOI: 10.1073/pnas.0800254105. View

Bobadilla J, Macek Jr M, Fine J, Farrell P . Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening. Hum Mutat. 2002; 19(6):575-606. DOI: 10.1002/humu.10041. View

Pak C, Sakhaee K, Fuller C . Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy. Trans Assoc Am Physicians. 1983; 96:294-305. View

Grskovic B, Pollaschek C, Mueller M, Stuhlmeier K . Expression of hyaluronan synthase genes in umbilical cord blood stem/progenitor cells. Biochim Biophys Acta. 2006; 1760(6):890-5. DOI: 10.1016/j.bbagen.2006.02.002. View

Pilewski J, Frizzell R . Role of CFTR in airway disease. Physiol Rev. 1999; 79(1 Suppl):S215-55. DOI: 10.1152/physrev.1999.79.1.S215. View

Schulz T, Schumacher U, Prante C, Sextro W, Prehm P . Cystic fibrosis transmembrane conductance regulator can export hyaluronan. Pathobiology. 2010; 77(4):200-9. DOI: 10.1159/000295859. View

Lin C, Cheng T, Tsai W, Tsai H, Hu K, Chang H . Loss of the respiratory enzyme citrate synthase directly links the Warburg effect to tumor malignancy. Sci Rep. 2012; 2:785. PMC: 3492867. DOI: 10.1038/srep00785. View

Jojovic M, Delpech B, Prehm P, Schumacher U . Expression of hyaluronate and hyaluronate synthase in human primary tumours and their metastases in scid mice. Cancer Lett. 2002; 188(1-2):181-9. DOI: 10.1016/s0304-3835(02)00037-x. View

10.

Sies H, Akerboom T, Tager J . Mitochondrial and cytosolic NADPH systems and isocitrate dehydrogenase indicator metabolites during ureogensis from ammonia in isolated rat hepatocytes. Eur J Biochem. 1977; 72(2):301-7. DOI: 10.1111/j.1432-1033.1977.tb11253.x. View

11.

Mornon J, Lehn P, Callebaut I . Molecular models of the open and closed states of the whole human CFTR protein. Cell Mol Life Sci. 2009; 66(21):3469-86. PMC: 11115851. DOI: 10.1007/s00018-009-0133-0. View

12.

Szellas T, Nagel G . Apparent affinity of CFTR for ATP is increased by continuous kinase activity. FEBS Lett. 2003; 535(1-3):141-6. DOI: 10.1016/s0014-5793(02)03892-9. View

13.

Schwille P, Scholz D, Paulus M, Engelhardt W, Sigel A . Citrate in daily and fasting urine: results of controls, patients with recurrent idiopathic calcium urolithiasis, and primary hyperparathyroidism. Invest Urol. 1979; 16(6):457-62. View

14.

Nowakowska E, Schulz T, Molenda N, Schillers H, Prehm P . Recovery of ΔF508-CFTR function by analogs of hyaluronan disaccharide. J Cell Biochem. 2011; 113(1):156-64. DOI: 10.1002/jcb.23339. View

15.

Terribile M, Capuano M, Cangiano G, Carnovale V, Ferrara P, Petrarulo M . Factors increasing the risk for stone formation in adult patients with cystic fibrosis. Nephrol Dial Transplant. 2006; 21(7):1870-5. DOI: 10.1093/ndt/gfl067. View

16.

Engelen M, Com G, Deutz N . Protein is an important but undervalued macronutrient in the nutritional care of patients with cystic fibrosis. Curr Opin Clin Nutr Metab Care. 2014; 17(6):515-20. PMC: 5241003. DOI: 10.1097/MCO.0000000000000100. View

17.

Pratt S, Shepard R, Kandasamy R, Johnston P, Perry 3rd W, Dantzig A . The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites. Mol Cancer Ther. 2005; 4(5):855-63. DOI: 10.1158/1535-7163.MCT-04-0291. View

18.

Gorji Z, Modaresi M, Yekanni-Nejad S, Rezaei N, Mahmoudi M . Comparing effects of low glycemic index/high-fat, high-calorie diet and high-fat, high-calorie diet on cytokine levels of patients with cystic fibrosis: A randomized controlled clinical trial. Eur Cytokine Netw. 2020; 31(1):32-38. DOI: 10.1684/ecn.2020.0442. View

19.

Gibney E, Goldfarb D . The association of nephrolithiasis with cystic fibrosis. Am J Kidney Dis. 2003; 42(1):1-11. DOI: 10.1016/s0272-6386(03)00403-7. View

20.

Spivacow F, Negri A, Polonsky A, Del Valle E . Long-term treatment of renal lithiasis with potassium citrate. Urology. 2010; 76(6):1346-9. DOI: 10.1016/j.urology.2010.02.029. View